000 | 03175nam a22005295i 4500 | ||
---|---|---|---|
001 | 978-0-387-25752-5 | ||
003 | DE-He213 | ||
005 | 20161121230854.0 | ||
007 | cr nn 008mamaa | ||
008 | 100301s2005 xxu| s |||| 0|eng d | ||
020 |
_a9780387257525 _9978-0-387-25752-5 |
||
024 | 7 |
_a10.1007/b135898 _2doi |
|
050 | 4 | _aHD87-87.55 | |
072 | 7 |
_aKCP _2bicssc |
|
072 | 7 |
_aPOL024000 _2bisacsh |
|
082 | 0 | 4 |
_a338.9 _223 |
245 | 1 | 0 |
_aImproving Healthcare _h[electronic resource] : _bA Dose of Competition A Report By The Federal Trade Commission and Department of Justice (July, 2004), with various Supplementary Materials / _cedited by David Hyman. |
246 | 3 | _aReport By The Federal Trade Commission and Department of Justice (July, 2004), with various Supplementary Materials | |
264 | 1 |
_aBoston, MA : _bSpringer US, _c2005. |
|
300 |
_aXV, 431 p. _bonline resource. |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
347 |
_atext file _bPDF _2rda |
||
490 | 1 |
_aDevelopments in Health Economics and Public Policy, _x0927-4987 ; _v9 |
|
505 | 0 | _aExecutive Summary -- Overview/Background -- Industry Snapshot and Competition Law: Physicians -- Industry Snapshot: Hospitals -- Competition Law: Hospitals -- Industry Snapshot: Insurance and Other Third Party Payment Programs -- 6: Competition Law: Insurers -- Industry Snapshot and Competition Law: Pharmaceuticals -- Miscellaneous Subjects. | |
520 | _aImproving Healthcare: A Dose of Competition systematically examines the American health care system from a competition-oriented perspective. The volume surveys the performance of each major sector of the health care system, and identifies impediments to more effective competition. Improving Healthcare examines such issues as competition v. regulation, public and private sector approaches to health care financing, cross-subsidies, licensure, provider market concentration, financial and clinical integration, payment for performance, quality, pharmacy benefit managers, direct-to-consumer advertising of pharmaceuticals, certificates of need, mandates, unionization, the significance of organizational status (nonprofit v. for-profit), and the role of antitrust and consumer protection in health care. It offers concrete recommendations to improve the quality and cost-effectiveness of the American health care marketplace. | ||
650 | 0 | _aHealth informatics. | |
650 | 0 | _aMedical laws and legislation. | |
650 | 0 | _aEconomic policy. | |
650 | 0 | _aSocial policy. | |
650 | 0 | _aLaw and economics. | |
650 | 1 | 4 | _aEconomics. |
650 | 2 | 4 | _aEconomic Policy. |
650 | 2 | 4 | _aLaw and Economics. |
650 | 2 | 4 | _aMedical Law. |
650 | 2 | 4 | _aHealth Informatics. |
650 | 2 | 4 | _aSocial Policy. |
700 | 1 |
_aHyman, David. _eeditor. |
|
710 | 2 | _aSpringerLink (Online service) | |
773 | 0 | _tSpringer eBooks | |
776 | 0 | 8 |
_iPrinted edition: _z9780387257518 |
830 | 0 |
_aDevelopments in Health Economics and Public Policy, _x0927-4987 ; _v9 |
|
856 | 4 | 0 | _uhttp://dx.doi.org/10.1007/b135898 |
912 | _aZDB-2-SBE | ||
950 | _aBusiness and Economics (Springer-11643) | ||
999 |
_c505202 _d505202 |